- Left ventricular hypertrophy
- Hypokinesia of the basal inferior, posterior, and septal segments; hypokinesia of the mid-lateral and mid-posterior segments
- Eccentric mitral valve insufficiency of grade I–II
A 60-year-old male patient (170cm, 84kg, BMI 29kg/m²) with a history of type 2 diabetes mellitus presented for follow-up of known myocardial dysfunction. He reported mild symptoms, including reduced exercise tolerance. Given his risk profile – including dyslipidemia, family history of coronary artery disease, and diabetes - a coronary angiogram was recommended.
His past medical history included:
Type 2 Diabetes Mellitus, onset in 2021
HbA1c 7% under medication with Metformin and Abasaglar
Suspected diabetic polyneuropathy
Bilateral mediasclerosis
Current echocardiographic findings:
Aortic sclerosis with a small plaque
Cardiovascular risk factors (CVRF): Dyslipoproteinemia, family history of coronary artery disease (CAD)
Small axial hiatal hernia
Medications:
Meformin: 500 mg 1-0-1
Abasaglar: 0-0-0-14IE
Semaglutid (was added currently): 0,25mg s.c.1x per week
Atorvastatin 20mg: 0-0-1
Ranexa 375mg: 1-0-1
Vit. D 2000IE: 1-0-0
Angio and echo
Coronary angiography revealed a severe three-vessel disease with severe proximal LAD stenosis, severe proximal circumflex artery stenosis, and RCA occlusion with retrograde perfusion (10th June 2025). Echocardiography showed a mild left ventricular hypertrophy, ejection fraction 43%, very eccentric mitral regurgitation (uncertain grading).
Disclaimer
This case report and/or content does not reflect the opinion of iHF or iheartfunction.com, nor does it engage their responsibility.